Miniature American Shepherd Age Calculator

MDR1 (Multi-Drug Resistance 1) gene mutation causes a defect in the blood-brain barrier's P-glycoprotein pump, making affected dogs unable to remove certain drugs from their brain. This results in potentially fatal neurotoxic reactions to common medications including ivermectin (found in some heartworm preventatives), loperamide (Imodium), and certain anesthetics and chemotherapy drugs. Approximately 50% of Miniature American Shepherds carry at least one copy of the MDR1 mutation, and 25% may be homozygous (mutant/mutant) with full sensitivity.

Prevention: DNA testing for the MDR1 mutation is essential and should be done before any medication is administered. Results must be shared with all veterinary providers and noted prominently in the dog's medical record. Use only MDR1-safe heartworm preventatives (milbemycin oxime at standard dose is safe). Avoid ivermectin, loperamide, acepromazine, and other P-glycoprotein substrate drugs in affected dogs. The Washington State University Veterinary Clinical Pharmacology Lab maintains a current list of drugs to avoid.

Symptoms: excessive drooling after medication exposure, tremors and incoordination, disorientation and blindness, seizures, coma and death in severe cases

Hip dysplasia in Miniature American Shepherds involves abnormal development of the hip joint, where the femoral head and acetabulum do not fit together properly. Despite the breed's smaller size, hip dysplasia is a significant concern, particularly given the high-impact activities (agility jumping, herding) that many MAS dogs participate in. The condition causes progressive joint deterioration, cartilage damage, and arthritis. Affected dogs may show reduced performance in sports before overt lameness develops.

Prevention: Select breeders who OFA-certify hips on breeding stock. Maintain lean body condition throughout life, particularly during the rapid growth phase. Avoid repetitive high-impact jumping during the first 14 months while growth plates are open. For agility dogs, ensure proper jump training technique and appropriate jump heights. Supplement with joint-supporting nutrients from middle age.

Symptoms: reluctance to jump or climb, especially notable in agility dogs, stiffness after rest or intense exercise, bunny-hopping gait when running, decreased exercise enthusiasm, clicking or popping from hip joint

Idiopathic epilepsy is a neurological condition causing recurrent seizures without an identifiable structural cause. The Miniature American Shepherd shares the predisposition to epilepsy seen in the Australian Shepherd breed from which it was developed. Seizures typically begin in young adulthood and range from mild focal episodes (twitching, staring) to severe generalized tonic-clonic convulsions. The condition is lifelong and requires medication management, but most affected dogs can live active, fulfilling lives with proper treatment.

Prevention: There is no prevention for genetic epilepsy, but responsible breeding practices reduce incidence. Do not breed affected dogs or known producers of epileptic offspring. If diagnosed, maintain strict medication schedules, minimize stress, and keep a detailed seizure diary. Anti-epileptic medications must be MDR1-safe — inform your veterinarian of MDR1 status before starting any epilepsy treatment.

Symptoms: whole-body convulsions with loss of consciousness, paddling of legs and jaw chomping, excessive salivation during episodes, loss of bladder or bowel control during seizures, post-ictal confusion, pacing, and temporary blindness

Hereditary cataracts involve progressive clouding of the lens of one or both eyes, impairing vision. In the Miniature American Shepherd, cataracts can develop at various ages but most commonly appear in young to middle adulthood. The condition is inherited and distinct from age-related cataracts that develop in elderly dogs. Hereditary cataracts may progress slowly or rapidly, and in some cases lead to secondary complications such as lens luxation and glaucoma. Surgical removal of the cataract lens can restore vision in many cases.

Prevention: Annual CERF eye examinations can detect early cataract formation before significant vision loss occurs. Select breeders who annually certify eyes clear of hereditary cataracts. HSF4 gene testing may be available for some cataract forms. Surgical cataract removal has a high success rate for vision restoration and should be discussed with a veterinary ophthalmologist if cataracts progress. Antioxidant supplementation may help slow progression in early-stage cataracts.

Symptoms: cloudy, white, or bluish appearance in the eye, difficulty catching treats or tracking objects, bumping into objects on the affected side, changes in eye color or reflection, secondary redness or squinting if complications develop

PRA is an inherited degenerative eye disease causing progressive loss of vision, eventually leading to blindness. The Miniature American Shepherd is predisposed to prcd-PRA (progressive rod-cone degeneration), with a known genetic mutation that can be identified through DNA testing. The condition begins with loss of night vision as rod photoreceptors degenerate, followed by progressive daytime vision loss as cone cells are affected. The disease is painless and progresses over months to years, and affected dogs typically adapt well to gradual vision loss.

Prevention: DNA testing for prcd-PRA is available and should be performed on all breeding stock. Both parents should be tested, and affected-to-carrier breeding should be avoided. Annual CERF eye examinations can detect early retinal changes before symptoms appear. There is no treatment to reverse PRA, but early identification allows adaptation of the home environment to support a visually impaired dog.

Symptoms: difficulty navigating in dim light or darkness, bumping into objects in unfamiliar settings, dilated pupils that respond slowly to light, increased eye shine (tapetal reflection), reluctance to enter dark rooms or go outside at night